Coronavirus Treatment Drugs Market

The coronavirus (COVID-19) is an infectious disease caused by the novel coronavirus. Those affected by COVID-19 are likely to experience mild to moderate respiratory illness and recover without requiring special treatment, but people in the age group of 50 years and above, and those and suffering from other health disorders such as hypertension, diabetes, and kidney failure are at a severe risk of infection and require specific treatment. Moreover, currently there is no medication for treating the coronavirus, and health physicians are suggesting corticosteroids, anti-viral therapies for individuals with severe symptoms.

Coronavirus Treatment Drugs Market contains market size and forecasts of Coronavirus Treatment Drugs in Global, including the following market information:

Global Coronavirus Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Coronavirus Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Corticosteroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Coronavirus Treatment Drugs include Serum Institute of India, Pfizer Inc, AstraZeneca Plc, Bharat Biotech International Limited, Cadila Healthcare Limited, Johnson & Johnson, Moderna, GlaxoSmithKline Plc and CanSino Biologics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Coronavirus Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Coronavirus Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Coronavirus Treatment Drugs Market Segment Percentages, by Type, 2021 (%)

Corticosteroids

Anti-viral

Monoclonal Antibodies

Kinase Inhibitors

Others

Global Coronavirus Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Coronavirus Treatment Drugs Market Segment Percentages, by Application, 2021 (%)

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Global Coronavirus Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Coronavirus Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Coronavirus Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Coronavirus Treatment Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Serum Institute of India

Pfizer Inc

AstraZeneca Plc

Bharat Biotech International Limited

Cadila Healthcare Limited

Johnson & Johnson

Moderna

GlaxoSmithKline Plc

CanSino Biologics

Sinovac Biotech

Novavax, Inc

Glenmark Pharmaceuticals Limited

Dr. Reddy's Laboratories

Merck & Co., Inc